Celltrion is a biopharmaceutical company in Korea that specializes in monoclonal antibody capabilities. Founded in 2002, the company develops, manufacturers, and distributes products that promote human health to major markets around the world. Celltrion operates one of the largest state-of-the-art mammalian cell culture plants with a total production capacity of 140,000L, including both purification suites and fill-finish capabilities. Additionally, Celltrion’s plant was the first commercial mammalian cell culture facility to receive US FDA approval in Asia.